MX9301535A - Material proteinaceo biologicamente activo aislado y purificado. - Google Patents
Material proteinaceo biologicamente activo aislado y purificado.Info
- Publication number
- MX9301535A MX9301535A MX9301535A MX9301535A MX9301535A MX 9301535 A MX9301535 A MX 9301535A MX 9301535 A MX9301535 A MX 9301535A MX 9301535 A MX9301535 A MX 9301535A MX 9301535 A MX9301535 A MX 9301535A
- Authority
- MX
- Mexico
- Prior art keywords
- biologically active
- purified
- present
- proteinaceous material
- material isolated
- Prior art date
Links
- 239000000463 material Substances 0.000 title abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000008468 bone growth Effects 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 230000001582 osteoblastic effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere al desarrollo de factores de crecimiento de huesos como terapéuticos para la prevención y tratamiento de condiciones patológicas que implican el tejido óseo. La presente invención provee factores proteináceos biológicamente activos que comprenden polipéptidos que contienen la secuencia de aminoácidos M-A-G-L-G-D-E-F-G-D, (X) F E T L F G A/V E D V I / D A L Q F V C G D, o A-Y-I-P-I-E-T-L-E-G-I/G-E-L-V-D/Q-T-G/L-Q-F o fragmentos biológicamente activos o análogos de secuencia de los mismos. Entre las propiedades biológicas de los materiales proteináceos de la presente invención están la capacidad de promover el crecimiento y/o diferenciación de células osteoblásticas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85541592A | 1992-03-18 | 1992-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9301535A true MX9301535A (es) | 1994-03-31 |
Family
ID=25321219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9301535A MX9301535A (es) | 1992-03-18 | 1993-03-18 | Material proteinaceo biologicamente activo aislado y purificado. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5408041A (es) |
| EP (1) | EP0728142A4 (es) |
| JP (1) | JPH07505161A (es) |
| AU (1) | AU3921993A (es) |
| CA (1) | CA2132219A1 (es) |
| MX (1) | MX9301535A (es) |
| WO (1) | WO1993019085A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5712249A (en) * | 1994-09-08 | 1998-01-27 | Ciba-Geigy Corporation | Use of insulin-like growth factors I and II for inhibition of inflammatory response |
| US6124262A (en) * | 1995-03-17 | 2000-09-26 | The Regents Of The University Of California | Compositions and methods for reducing adhesiveness of defective red blood cells |
| WO1997024434A1 (en) * | 1995-12-29 | 1997-07-10 | Alg Company | Expansion of bone marrow stromal cells |
| DE69523956T2 (de) * | 1995-12-29 | 2002-07-18 | Alg Company, Marlborough | Vermehrung von knochenmarksstützzellen |
| CA2227312C (en) * | 1997-06-26 | 2002-11-19 | Jeong S. Sim | Nutraceutical antler powder and a method of producing same |
| US6093421A (en) * | 1999-08-31 | 2000-07-25 | Biotics Research Corporation | Maca and antler for augmenting testosterone levels |
| KR100397220B1 (ko) * | 2000-07-13 | 2003-09-13 | 전길자 | 녹용으로부터 추출된 골형성 촉진 물질 및 그의 추출방법 |
| US20050153359A1 (en) * | 2002-03-11 | 2005-07-14 | Schaefer Allan L. | Method for the evaluation of velvet antler |
| NZ526157A (en) * | 2003-05-27 | 2006-01-27 | Velvet Antler Res New Zealand | Method for the extraction of deer antler and use of the extract therefrom |
| WO2011034447A1 (en) * | 2009-09-15 | 2011-03-24 | Andeer (Nz) Limited | Active composition from deer antler and methods of use |
| EA201290577A1 (ru) | 2010-01-26 | 2013-06-28 | Стем Селз Спин С.А. | Клеточный гомогенат из стволовых клеток, полученных из растущих рогов оленя, способ его получения и применения |
| CN114569634B (zh) * | 2022-03-14 | 2024-03-12 | 广州医科大学附属口腔医院 | 鹿茸间充质干细胞条件培养基在牙周炎药物中的用途 |
| CN114720592B (zh) * | 2022-03-25 | 2023-04-18 | 山东省食品药品检验研究院 | 一种含有鹿源成分的中药制剂中掺伪的筛查方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4795804A (en) * | 1983-08-16 | 1989-01-03 | The Regents Of The University Of California | Bone morphogenetic agents |
| US5108753A (en) * | 1988-04-08 | 1992-04-28 | Creative Biomolecules | Osteogenic devices |
| US5106626A (en) * | 1988-10-11 | 1992-04-21 | International Genetic Engineering, Inc. | Osteogenic factors |
-
1993
- 1993-03-18 AU AU39219/93A patent/AU3921993A/en not_active Abandoned
- 1993-03-18 WO PCT/US1993/002435 patent/WO1993019085A1/en not_active Application Discontinuation
- 1993-03-18 JP JP5516703A patent/JPH07505161A/ja active Pending
- 1993-03-18 MX MX9301535A patent/MX9301535A/es unknown
- 1993-03-18 EP EP93908377A patent/EP0728142A4/en not_active Withdrawn
- 1993-03-18 CA CA002132219A patent/CA2132219A1/en not_active Abandoned
-
1994
- 1994-01-13 US US08/180,572 patent/US5408041A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07505161A (ja) | 1995-06-08 |
| WO1993019085A1 (en) | 1993-09-30 |
| AU3921993A (en) | 1993-10-21 |
| EP0728142A4 (en) | 1997-05-02 |
| US5408041A (en) | 1995-04-18 |
| EP0728142A1 (en) | 1996-08-28 |
| CA2132219A1 (en) | 1993-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9301535A (es) | Material proteinaceo biologicamente activo aislado y purificado. | |
| IL197686A0 (en) | Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith | |
| ES2140082T3 (es) | Composiciones peptidicas con actividad de tipo factor de crecimiento. | |
| ATE397626T1 (de) | Rgd-angereicherte gelatine-ähnliche proteine mit verstärkter zellbindung | |
| EP0590156A4 (en) | Novel, physiologically active protein and hemopoietic stem cell growth promoter | |
| IL93360A (en) | Bactericidal/permeability increasing protein or biologically active analogs thereof and pharmaceutical compositions containing them | |
| ES2088006T3 (es) | Composiciones farmaceuticas osteoinductivas. | |
| MX9207334A (es) | Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene | |
| KR900700617A (ko) | 뼈 및 연골 유도 조성물 | |
| ATE142693T1 (de) | Herstellung des vaskulären endothelialen zellwachstumsfaktors | |
| ES2127757T3 (es) | Composiciones bmp-9. | |
| CA2213533A1 (en) | Resorbable extracellular matrix for reconstruction of cartilage tissue | |
| PT1061940E (pt) | Utilizacao de foliestatina para a producao de um medicamento para o tratamento de disturbios relacionados com os musculos | |
| ES2121479T3 (es) | Solucion estabilizadora para proteinas y peptidos. | |
| HRP20040347B1 (en) | Keratynocites which may be used as biologically active substances for the treatment of wounds | |
| DE68928667D1 (de) | Peptide als arzneimittel | |
| PT91971A (pt) | Metodo para a producao de camadas epidermicas de cultura | |
| RU94036776A (ru) | Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы | |
| ATE211391T1 (de) | Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung | |
| KR950702577A (ko) | 아젤레높시스 아페르타(agelenopsis aperta)로 부터의 칼슘 채널 차단 폴리펩티드(calcium channel blocking polypeptide from agelenopsis aperta) | |
| BR0014183A (pt) | Composições farmaceuticas e metodos de uso de proteìna relacionada frizzled secretada | |
| DE69725882D1 (de) | Adenovirus e4 proteine für induktion von zelltod | |
| SE8902507D0 (sv) | Neutrofil-aktiverande faktor | |
| ATE193305T1 (de) | Osteogene wachstums-oligopeptide und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten |